Titan Pharmaceuticals logo
Titan Pharmaceuticals TTNP
$ 3.38 3.36%

Quarterly report 2024-Q2
added 08-15-2024

report update icon

Titan Pharmaceuticals Accounts Receivables 2011-2024 | TTNP

Annual Accounts Receivables Titan Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
46 K 36 K 112 K 884 K 993 K 1.74 M 65 K 3.59 M 4.21 M 3.97 M 4.82 M 4.65 M 3.72 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
4.82 M 36 K 2.22 M

Quarterly Accounts Receivables Titan Pharmaceuticals

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
38 K 134 K 46 K 26 K 9 K 8 K 36 K 49 K 101 K 218 K 112 K 265 K 103 K 398 K 884 K 884 K 884 K 884 K 438 K 993 K 993 K 993 K 1.74 M 1.74 M 1.74 M 1.74 M 65 K 65 K 65 K 65 K 3.59 M 3.59 M 3.59 M 3.59 M 4.21 M 4.21 M 4.21 M 4.21 M 3.97 M 3.97 M 3.97 M 3.97 M 4.82 M 4.82 M 4.82 M 4.82 M 4.65 M 4.65 M 4.65 M 4.65 M 3.72 M 3.72 M 3.72 M 3.72 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
4.82 M 8 K 2.14 M